Clinical Trial Update: An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides [Phase 2]

View source ↗

Summary

An open-label Phase 2 study evaluating the safety and efficacy of a 0.04% topical mechlorethamine formulation in Mycosis fungoides has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides

Drugs mentioned

• Mechlorethamine (mechlorethamine)

Snippet

Sponsor: Yaupon Therapeutics | Conditions: Mycosis Fungoides | Phase 2 | Status: COMPLETED